Strides Pharma gets manufacturing supplement approved for polyethylene glycol 3350
FDA approved a chemistry, manufacturing, and controls supplement for Strides Pharma's ANDA for polyethylene glycol 3350 oral solution.
Strides Pharma had one regulatory item recorded this week.
- A supplemental application (submission number 19) for polyethylene glycol 3350, an oral for-solution product available in 17GM/PACKET and 17GM/SCOOPFUL strengths, was approved under a manufacturing (CMC) submission class.1 The submission status date is listed as 2026-09-11.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.